Shared on01 Aug 25Fair value Decreased 10%
Consensus revenue growth forecasts for PetMed Express have deteriorated further into negative territory, driving a lower analyst price target from $3.35 to $3.00. What's in the News PetMed Express received a notice from Nasdaq for not timely filing its annual report, with a deadline to submit a compliance plan and potentially regain compliance by late December.